Full Press Release Details
Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock.
REGN
Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
Key Takeaway: Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock